BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35111844)

  • 1. SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer.
    Zhang HP; Wu J; Liu ZF; Gao JW; Li SY
    Biomed Res Int; 2022; 2022():1398268. PubMed ID: 35111844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers.
    Hu H; Zhang H; Ge W; Liu X; Loera S; Chu P; Chen H; Peng J; Zhou L; Yu S; Yuan Y; Zhang S; Lai L; Yen Y; Zheng S
    Clin Cancer Res; 2012 Oct; 18(19):5438-48. PubMed ID: 22891198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer.
    Yu SJ; Yu JK; Ge WT; Hu HG; Yuan Y; Zheng S
    World J Gastroenterol; 2011 Apr; 17(15):2028-36. PubMed ID: 21528083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying liver metastasis-related hub genes in breast cancer and characterizing
    Chen M; Zheng W; Fang L
    PeerJ; 2023; 11():e15311. PubMed ID: 37180578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression.
    Hurley PJ; Hughes RM; Simons BW; Huang J; Miller RM; Shinder B; Haffner MC; Esopi D; Kimura Y; Jabbari J; Ross AE; Erho N; Vergara IA; Faraj SF; Davicioni E; Netto GJ; Yegnasubramanian S; An SS; Schaeffer EM
    Cancer Res; 2015 Oct; 75(20):4322-34. PubMed ID: 26294211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.
    Wu DM; Shi J; Liu T; Deng SH; Han R; Xu Y
    Cancer Biomark; 2018 Feb; 21(2):355-365. PubMed ID: 29103025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
    Zhang H; Dong S; Feng J
    J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPARCL1, a Novel Prognostic Predictive Factor for GI Malignancies: a Meta-Analysis.
    Hu H; Cai W; Zheng S; Ge W
    Cell Physiol Biochem; 2017; 44(4):1485-1496. PubMed ID: 29190626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPARCL1 exhibits different expressions in left- and right-sided colon cancer and is downregulated via DNA methylation.
    Hu H; Wu D; Liu X; Yu H; Xu J; Cai W; Huang Y; Bai R; Zhang J; Gu Y; Zheng S; Ge W
    Epigenomics; 2021 Aug; 13(16):1269-1282. PubMed ID: 34435512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
    Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
    Front Immunol; 2022; 13():887048. PubMed ID: 35784334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
    Yu S; Chen M; Xu L; Mao E; Sun S
    Front Immunol; 2023; 14():1175490. PubMed ID: 37090726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of reduced SPARCL1 expression in human breast cancer.
    Cao F; Wang K; Zhu R; Hu YW; Fang WZ; Ding HZ
    Asian Pac J Cancer Prev; 2013; 14(1):195-200. PubMed ID: 23534723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
    Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
    J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
    Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
    PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
    Yuan J; Xie A; Cao Q; Li X; Chen J
    Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
    Wu B; Tao L; Yang D; Li W; Xu H; He Q
    Biomed Res Int; 2020; 2020():2719739. PubMed ID: 32908876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.